While the expression of other candidates, including RORA, RORC, and THRB, remained unchanged, that of PPARA significantly decreased as NAFLD progressed to steatosis and NASH, and showed a negative correlation with that of MIR20B (Figure 2—figure supplement 3). This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.